Chemiluminescent determination of leukocyte alkaline phosphatase: An advantageous alternative to the cytochemical assay

Journal of Clinical Laboratory Analysis

Volumn 21, Issue 2, 2007, Pages 91-96

  Kanegae, Marília P P ^a   Ximenes, Valdecir F ^a   Falcão, Roberto P ^b   Colturato, Virgílio A R ^c   De Mattos, Éderson R ^c   Brunetti, Iguatemy L ^a   Da Fonseca, Luiz Marcos ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital Amaral Carvalho   (Brazil)

Author keywords

Chemiluminescence; Chronic myeloid leukemia; Immulite (AMPPD); Leukemoid reactions; Leukocyte alkaline phosphatase

Indexed keywords

3 (2' SPIROADAMANTANE) 4 METHOXY 4 (3'' PHOSPHORYLOXY)PHENYL 1,2 DIOXETANE; ALKALINE PHOSPHATASE; REAGENT; UNCLASSIFIED DRUG;

ANALYTICAL EQUIPMENT; ARTICLE; CHEMOLUMINESCENCE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOCHEMISTRY; ENZYME ASSAY; HUMAN; HUMAN CELL; LEUKEMOID REACTION; LEUKOCYTE; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA; QUANTITATIVE ANALYSIS;

ADAMANTANE; ALKALINE PHOSPHATASE; CHEMILUMINESCENT MEASUREMENTS; HISTOCYTOCHEMISTRY; HUMANS; INDICATORS AND REAGENTS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMOID REACTION; LUMINESCENCE; NEUTROPHILS;

EID: 34047210910     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20140     Document Type: Article

References (21)

1. Rambaldi A, Terao M, Bettoni S, Bassan R, Barbui T, Garattini E. Difference in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytes. Blood 1989;73:1113-1115.
2. Kaplow LS. Leukocyte alkaline phosphatase cytochemistry: applications and methods. Ann NY Acad Sci 1968;155:911-947.
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Gallon DAG, Gralnick HR. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-199.
4. De Palma L, Delgado P, Werner M. Diagnostic discrimination and cost effective assay strategy for leukocyte alkaline phosphatase. Clin Chim Acta 1995;6:83-90.
5. Hofmann WK, Stauch M, Höffken K. Impaired granulocytic function in patients with acute leukaemia: only partial normalization after successful remission-inducing treatment. Clin Res Clin Oncol 1998;124:113-116.
6. Lichtman MA, Liesveld JL. Chronic myelogenous leukemia and related disorders. In: Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT, editors. Williams hematology. 7th ed. New York: McGraw-Hill Medical; 2006. p 1266.
7. Prchal JT, Beutler E. Primary and secondary polycythemias (erythrocytosis). In: Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT, editors. Williams Hematology. 7th ed. New York: McGraw-Hill Medical; 2006. p 788-790.
8. Stasi R, Bruno A, Venditti A, et al. Leukocyte alkaline phosphatase score in plasma cell dyscrasias: correlation with disease severity and circulating levels of granulocyte colony stimulating factor. Leuk Lymphoma 1995;17:479-483.
9. Walach N, Gur Y. Leukocyte alkaline phosphatase as a probable predictor of the metastatic state in breast and colon cancer patients. Oncology 1995;52:12-18.
10. Walach N, Gur Y. Leukocyte alkaline phosphatase and carcinoembryonic antigen in lung cancer patients. Oncology 1993;50:279-284.
11. Bronstein I, Edwards B, Voyta JC. 1,2-Dioxetanes: novel chemiluminescent enzyme substrates. Applications to immunoassays. J Biolumin Chemilumin 1989;4:99-111.
12. Kricka L, Voyta JC, Bronstein I. Chemiluminescent methods for detecting and quantitating enzyme activity. Methods Enzym. 2000;300:381-382.
13. Ciz M, Lojek A. Improved dextran preparation of human leukocytes for chemiluminescence analysis of the oxidative burst of polymorphonuclear cells. Clin Lab Haematol 1997;19:49-51.
14. Burtis CA, Ashwood ER. Fundamentals in clinical chemistry. 5th ed. Philadelphia: W.B. Saunders; 2001. p 366-369.
15. Da Costa M, Ximenes VF, Brunetti IL, Falcão RP, Fonseca LM. p-Iodophenol-enhanced luminol chemiluminescent assay applied to discrimination between acute lymphoblastic and minimally differentiated acute myeloid (FAB-M0) or acute megacaryoblastic (FAB-M7) leukemias. Hematol J 2004;5:496-499.
16. Fonseca LM, Yavo B, Catalani LH, Falcão RP, Brunetti IL, Campa A. Chemiluminescent determination of esterases in monocytes. J Biolumin Chemilumin 1998;13:195-200.
17. Fonseca LM, Brunetti IL, Campa A, Catalani LH, Calado RT, Falcão RP. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay. Hematol J 2003;4:26-30.
18. Fonseca LM, Brunetti IL, Rego EM, Garcia AB, Cilento G, Falcão RP. Characterization of myeloid or lymphoid acute leukemia by chemiluminescence assay. Comparison with immunocytochemistry using an antimyeloperoxidase antibody. Acta Haematol 1993;1:19-24.
19. Rambaldi A, Masuhara K, Borleri GM, et al. Flow cytometry of leukocyte alkaline phosphatase in normal and pathologic leukocytes. Br J Haematol 1997;96:815-822.
20. Ghanei M, Vosoghi AA. An epidemiologic study to screen for chronic myeloid leukemia in war victims exposed to mustard gas. Environ Health Perspect 2002;110:519-521.
21. Ganti AK, Potti A, Mehdi AS. Chromosomal anomalies in two coexistent myeloproliferative disorders. Cancer Genet Cytogenet 2003;145:172-175.